Frichs Biotech IVS — Credit Rating and Financial Key Figures

Frichs Biotech IVS (CVR number: 38147455) is a company from AARHUS. The company recorded a gross profit of 67.3 kDKK in 2017. The operating profit was 67.3 kDKK, while net earnings were 18.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was 10.1 %, which can be considered good but Return on Equity (ROE) was 90.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 3 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. Frichs Biotech IVS's liquidity measured by quick ratio was 1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.